TriLinc Global Impact Fund, LLC
TRLC
$1.15
-$0.10-8.00%
| Weiss Ratings | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | C- | |||
| Rating Factors | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Good | |||
| Solvency Index | Excellent | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Very Weak | |||
| Beta / Standard Deviation | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -0.04 | |||
| Price History | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.00% | |||
| 30-Day Total Return | 0.00% | |||
| 60-Day Total Return | 0.00% | |||
| 90-Day Total Return | -37.84% | |||
| Year to Date Total Return | 0.00% | |||
| 1-Year Total Return | -62.90% | |||
| 2-Year Total Return | -74.44% | |||
| 3-Year Total Return | -74.44% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -62.30% | |||
| 52-Week Low % Change | 0.00% | |||
| Price | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $3.05 | |||
| 52-Week Low Price | $1.15 | |||
| 52-Week Low Price (Date) | Nov 12, 2024 | |||
| 52-Week High Price (Date) | Apr 02, 2024 | |||
| Valuation | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 69.30M | |||
| Enterprise Value | 68.42M | |||
| Price/Earnings (TTM) | 4.73 | |||
| Earnings Per Share (TTM) | 0.24 | |||
| Earnings Per Share Growth | -129.94% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.52 | |||
| Price/Book (Q) | 0.20 | |||
| Enterprise Value/Revenue (TTM) | 6.15 | |||
| Price | $1.15 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | 52.07 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 47.78M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 64.08% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 310 997 0580 | |||
| Address | 1230 Rosecrans Avenue Manhattan Beach, CA 90266 | |||
| Website | trilincglobalimpactfund.com | |||
| Country | United States | |||
| Year Founded | 2012 | |||
| Profitability | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 11.81% | |||
| Profit Margin | 74.42% | |||
| Management Effectiveness | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 0.41% | |||
| Return on Equity | 4.19% | |||
| Income Statement | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 120.50K | |||
| Total Revenue (TTM) | 15.59M | |||
| Revenue Per Share | $0.33 | |||
| Gross Profit (TTM) | 15.59M | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | 1.84M | |||
| Net Income (TTM) | 11.61M | |||
| Net Income Avl. to Common (TTM) | 11.61M | |||
| Total Revenue Growth (Q YOY) | 13.33% | |||
| Earnings Growth (Q YOY) | 251.27% | |||
| EPS Diluted (TTM) | 0.24 | |||
| EPS Diluted Growth (Q YOY) | 251.18% | |||
| Balance Sheet | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 878.00K | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 15.41M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 278.76M | |||
| Current Ratio (Q) | 3.886 | |||
| Book Value Per Share (Q) | $5.83 | |||
| Total Assets (Q) | 282.76M | |||
| Total Current Liabilities (Q) | 3.96M | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 4.01M | |||
| Total Common Equity (Q) | 278.76M | |||
| Cash Flow | TRLC - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | -7.44M | |||
| Net Change in Cash (TTM) | 617.00K | |||
| Levered Free Cash Flow (TTM) | 12.58M | |||
| Cash from Operations (TTM) | 8.05M | |||
